Category: Technology
Latest Technology News
A+E, Cisco Test Mobile Ratings Technology #IBC2014 “Together with Cisco, we have been working to bring this technology to market,” explained Don Jarvis, senior VP of global engineering and technology A+E Networks in a statement. “In-home viewing on mobile devices is a growing option for subscribers who … Read more on Broadcasting & Cable Smart technology […]
Battery technology
Battery technology THE digital devices that rule modern life may be advancing at breakneck speed, but the rechargeable batteries that power them are making slower progress. The lithium-ion (Li-ion) batteries found in everything from smartphones and laptops to Teslas and … Read more on The Economist 5 Technology Trends for the Financial Industry Let's face it: […]
Wearable Technology
[youtube http://www.youtube.com/watch?v=1tIQHh7Rs_g&fs=1&rel=0] There’s an emerging technology that you can wear. Not to be behind the times, Ellen has come up with some of her own inventions. [youtube http://www.youtube.com/watch?v=bVzD4Jw8u4o&fs=1&rel=0] Facebook: https://www.facebook.com/2011teenagemom Instagram: 2011Teenagemom COMMENT ENJOY SUBSCRIBE! Video Rating: 4 / 5
Respected Vacation Rental Industry Executive Heather Weiermann Joins NAVIS
Bend, OR (PRWEB) September 09, 2014 NAVIS, the leading reservation sales and marketing system provider for the vacation rental, resort and hotel markets, announced respected vacation rental industry veteran Heather Weiermann joined NAVIS. Weiermann founded Southern California Vacation Rentals in 1999 and grew it to be one of San Diego’s leading vacation rental companies. In […]
Vicus Therapeutics Announces Phase II Data Demonstrating Overall Survival Benefit with VT-122 Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
MORRISTOWN, N.J (PRWEB) September 05, 2014 Vicus Therapeutics, an immuno-oncology company focused on bringing breakthrough immunotherapies to patients with solid-tumor cancers, announced positive results from a Phase II randomized, open-label, controlled clinical trial of its lead compound, VT-122, in combination with sorafenib, in patients with advanced hepatocellular carcinoma (HCC). In an intent-to-treat (ITT) population, investigators […]